International Journal of Clinical Case Reports 2024, Vol.14, No.5, 230-241 http://medscipublisher.com/index.php/ijccr 239 References Buchroithner J., Erhart F., Pichler J., Widhalm G., Preusser M., Stockhammer G., Nowosielski M., Iglseder S., Freyschlag C., Oberndorfer S., Bordihn K., Campe G., Hoffermann M., Ruckser R., Rössler K., Spiegl-Kreinecker S., Fischer M., Czech T., Visús C., Krumpl G., Felzmann T., and Marosi C., 2018, Audencel immunotherapy based on dendritic cells has no effect on overall and progression-free survival in newly diagnosed glioblastoma: a phase ii randomized trial, Cancers, 10(10): 372. https://doi.org/10.3390/cancers10100372 PMID: 30301187 PMCID: PMC6210090 Burg S., 2018, Correlates of immune and clinical activity of novel cancer vaccines, Seminars in Immunology, 39: 119-136. https://doi.org/10.1016/j.smim.2018.04.001 PMID: 29709421 Dillman R., 2015, Cancer vaccines: can they improve survival, Cancer Biotherapy and Radiopharmaceuticals, 30(4): 147-151. https://doi.org/10.1089/cbr.2014.1805 PMID: 25747158 Failing J., Ho T., Yadav S., Majithia N., Riaz I., Shin J., Schenk E., and Xie H., 2020, Safety of influenza vaccine in patients with cancer receiving pembrolizumab., JCO Oncology Practice, 16(7): 573-580. https://doi.org/10.1200/jop.19.00495 PMID: 32048920 PMCID: PMC8462591 Guo S., Gu D.N., and Chen X., 2024, Development and influencing factors of female cancers, Cancer Genetics and Epigenetics, 12(1): 27-36. https://doi.org/10.5376/cge.2024.12.0004 Hansen G., Gaudernack G., Brunsvig P., Cvancarova M., and Kyte J., 2015, Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination, Cancer Immunology, Immunotherapy, 64: 1609-1621. https://doi.org/10.1007/s00262-015-1766-5 PMID: 26498005 PMCID: PMC11029677 Janes M., Gottlieb A., Park K., Zhao Z., and Mitragotri S., 2023, Cancer vaccines in the clinic, Bioengineering and Translational Medicine, 9(1): e10588. https://doi.org/10.1002/btm2.10588 PMID: 38193112 PMCID: PMC10771564 Khaddour K., Kamel J., Meeder N., Ziqiao X., Sandra C., Pasquinelli M., Nguyen R., Liu L., Gadi V., Feldman L., and Weinberg F., 2023, Clinical outcomes in patients with metastatic non-small cell lung cancer and head and neck squamous cell cancer treated with immune checkpoint inhibitors according to COVID-19 vaccination status, Journal of Clinical Oncology, 41(16): e14696 https://doi.org/10.1200/jco.2023.41.16_suppl.e14696 Kyte J., Aamdal S., Dueland S., Sæbøe-Larsen S., Inderberg E., Madsbu U., Skovlund E., Gaudernack G., and Kvalheim G., 2016, Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells, OncoImmunology, 5(11): e1232237. https://doi.org/10.1080/2162402X.2016.1232237 PMID: 27999747 PMCID: PMC5139630 Kaczmarek M., Poznańska J., Fechner F., Michalska N., Paszkowska S., Napierała A., and Mackiewicz A., 2023, Cancer vaccine therapeutics: limitations and effectiveness-a literature review, Cells, 12(17): 2159. https://doi.org/10.3390/cells12172159 PMID: 37681891 PMCID: PMC10486481 Katsuda M., Miyazawa M., Ojima T., Katanuma A., Hakamada K., Sudo K., Asahara S., Endo I., Ueno M., Hara K., Yamada S., Fujii T., Satoi S., Ioka T., Ohira M., Akahori T., Kitano M., Nagano H., Furukawa M., Adachi T., and Yamaue H., 2019, A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy, Trials, 20(1): 242. https://doi.org/10.1186/s13063-019-3332-5 PMID: 31029154 PMCID: PMC6486956 Lakdawalla D., Shafrin J., Hou N., Peneva D., Vine S., Park J., Zhang J., Brookmeyer R., and Figlin R., 2017, Predicting real-world effectiveness of cancer therapies using overall survival and progression-free survival from clinical trials: empirical evidence for the ASCO value framework, Value in Health, 20(7): 866-875. https://doi.org/10.1016/j.jval.2017.04.003 PMID: 28712615 Lőrincz P., Kenéz L.A., Tóth S., Kiss V,. Varga Á., Csizmadia T., Simon-Vecsei Z., and Juhász G., 2019, Vps8 overexpression inhibits HOPS-dependent trafficking routes by outcompeting Vps41/Lt, Elife, 8: e45631. https://doi.org/10.7554/eLife.45631 PMID: 31194677 PMCID: PMC6592680 Lin M., Yuan Y., Liu S., Shi J., Long X., Niu L., Chen J., Li Q., and Xu K., 2015, Prospective study of the safety and efficacy of a pancreatic cancer stem cell vaccine, Journal of Cancer Research and Clinical Oncology, 141: 1827-1833. https://doi.org/10.1007/s00432-015-1968-4 PMID: 25860618
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==